|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：E934104 |
| 產(chǎn)品名稱：Etoricoxib-13C,d3 |
| 產(chǎn)品CAS： |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
E934104 |
| 名稱: |
Etoricoxib-13C,d3 |
| 別名: |
5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine-d5; Algix-d5; Arcoxia-d5; Etobrix-d5; Etocox-d5; Etoxib-d5; Etropain-d5; Kingcox-d5; MK 0663-d5; MK 663-d5; Tauxib-d5; Torcoxia-d5; |
| 參考CAS: |
未標(biāo)記：202409-33-4 |
| 分子式: |
C??¹³CH??D?ClN2O?S |
| 分子量: |
362.851 |
| 種類: |
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Etoricoxib-13C,d3, is the labeled analogue of Etoricoxib (E934100), a specific inhibitor of COX-2 . |
| 危險(xiǎn)品: |
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
